Canopy Growth (WEED) Competitors C$1.40 -0.12 (-7.89%) As of 07/29/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesBuy This Stock WEED vs. CMED, OGI, EMC, ICC, LEAF, MGW, BE, BLO, SL, and MJNShould you be buying Canopy Growth stock or one of its competitors? The main competitors of Canopy Growth include CanniMed Therapeutics (CMED), Organigram (OGI), Emblem (EMC), ICC Labs (ICC), Leaf Mobile (LEAF), Maple Leaf Green World (MGW), Beleave (BE), Cannabix Technologies (BLO), Supreme Cannabis Company Inc, (SL), and Cronos Group (MJN). These companies are all part of the "cannabis" industry. Canopy Growth vs. Its Competitors CanniMed Therapeutics Organigram Emblem ICC Labs Leaf Mobile Maple Leaf Green World Beleave Cannabix Technologies Supreme Cannabis Company Inc, Cronos Group Canopy Growth (TSE:WEED) and CanniMed Therapeutics (TSE:CMED) are both small-cap cannabis companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation. Do analysts rate WEED or CMED? Canopy Growth presently has a consensus price target of C$2.20, indicating a potential upside of 57.14%. Given Canopy Growth's stronger consensus rating and higher possible upside, research analysts clearly believe Canopy Growth is more favorable than CanniMed Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 3 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00CanniMed Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is WEED or CMED more profitable? CanniMed Therapeutics has a net margin of 0.00% compared to Canopy Growth's net margin of -201.27%. CanniMed Therapeutics' return on equity of 0.00% beat Canopy Growth's return on equity.Company Net Margins Return on Equity Return on Assets Canopy Growth-201.27% -108.18% -3.83% CanniMed Therapeutics N/A N/A N/A Do institutionals & insiders have more ownership in WEED or CMED? 9.4% of Canopy Growth shares are owned by institutional investors. 0.2% of Canopy Growth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media refer more to WEED or CMED? In the previous week, Canopy Growth had 1 more articles in the media than CanniMed Therapeutics. MarketBeat recorded 1 mentions for Canopy Growth and 0 mentions for CanniMed Therapeutics. Canopy Growth's average media sentiment score of 0.33 beat CanniMed Therapeutics' score of 0.00 indicating that Canopy Growth is being referred to more favorably in the media. Company Overall Sentiment Canopy Growth Neutral CanniMed Therapeutics Neutral Which has higher valuation & earnings, WEED or CMED? CanniMed Therapeutics has lower revenue, but higher earnings than Canopy Growth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCanopy GrowthC$519.68M0.43-C$1.05B-C$6.85-0.20CanniMed TherapeuticsN/AN/AN/AN/AN/A SummaryCanopy Growth beats CanniMed Therapeutics on 7 of the 10 factors compared between the two stocks. Get Canopy Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for WEED and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding WEED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WEED vs. The Competition Export to ExcelMetricCanopy GrowthDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$225.22MC$2.20BC$5.70BC$6.32BDividend Yield4.80%2.92%4.71%6.72%P/E Ratio-0.204.2428.2078.13Price / Sales0.43634.59390.571,321.37Price / Cash1.6310.3536.3283.29Price / Book0.2410.948.274.90Net Income-C$1.05BC$21.15BC$3.25BC$301.20M7 Day Performance-11.39%0.83%-2.00%-0.35%1 Month Performance-16.67%5.70%8.68%4.13%1 Year Performance-86.68%1.74%34.66%25.56% Canopy Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WEEDCanopy Growth1.4314 of 5 starsC$1.40-7.9%C$2.20+57.1%-86.3%C$225.22MC$519.68M-0.202,700CMEDCanniMed TherapeuticsN/AN/AN/AN/AC$668.44MN/A0.00147,000OGIOrganigram2.3065 of 5 starsC$1.99-1.0%C$3.33+67.1%-12.2%C$245.85MC$180.58M-4.21987EMCEmblemN/A$1.88+1.6%N/A+0.0%$245.45M$5.71M-9.89N/AICCICC LabsN/AC$1.62-5.8%N/A+0.0%C$223.64MC$533.68K95.29N/ANews CoverageGap UpLEAFLeaf MobileN/AN/AN/AN/AC$198.42MC$83.74M58.86150MGWMaple Leaf Green WorldN/AC$0.79+777.8%N/A+0.0%C$111.69MN/A0.00N/ANews CoverageGap UpBEBeleaveN/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading VolumeBLOCannabix TechnologiesN/AN/AN/AN/AC$0.00N/A0.00N/ANews CoverageGap DownSLSupreme Cannabis Company Inc,N/AN/AN/AN/AC$0.00N/A0.00N/AGap DownHigh Trading VolumeMJNCronos GroupN/AC$12.15-1.9%N/A+0.0%C$1.73BN/A0.007,600 Related Companies and Tools Related Companies CanniMed Therapeutics Alternatives Organigram Alternatives Emblem Alternatives ICC Labs Alternatives Leaf Mobile Alternatives Maple Leaf Green World Alternatives Beleave Alternatives Cannabix Technologies Alternatives Supreme Cannabis Company Inc, Alternatives Cronos Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:WEED) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredSmall Cap- AI Hospitals = Big OpportunityA tiny NASDAQ firm just launched a generative AI platform aimed at disrupting a $2 trillion healthcare market....Smallcaps Daily | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Canopy Growth Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Canopy Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
